Pfizer

Early bird savings on passes to TechCrunch Disrupt 2021 end this week

Tick tock, early-stage startup fans: If you plan to attend TechCrunch Disrupt 2021 (September 21-23), time is running out to score a pass to the world’s leading conference dedicated to tech startups

Industrial cybersecurity startup Claroty raises $140M in pre-IPO funding round

Claroty, an industrial cybersecurity company that helps customers protect and manage their Internet of Things (IoT) and operational technology (OT) assets, has raised $140 million in its latest, and p

Pfizer-BioNTech’s COVID-19 vaccine just got a lot easier to transport and distribute

The COVID-19 vaccine developed by Pfizer and BioNTech now has less stringent and extreme transportation requirements than when it debuted. Originally, the mRNA-based vaccine had to be maintained at ul

Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data

Another COVID-19 vaccine is almost ready to begin being distributed — a single-shot inoculation made by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary. The company just release

Moderna says it’s making variant-specific COVID-19 vaccines, but its existing vaccine should still work

Moderna has detailed some of the steps it’s taking to ensure that its vaccine remains effective in the face of emerging strains of the SARS-CoV-2 virus that leads to COVID-19. These include test

FDA authorizes Moderna’s COVID-19 vaccine for emergency use

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine, as expected after an independent panel commissioned by the administrat

FDA grants emergency use authorization for Pfizer’s COVID-19 vaccine, distribution to begin within days

The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the COVID-19 vaccine developed by Pfizer and its partner BioNTech, the New York Times first reported on

FDA panel recommends approving Pfizer’s COVID-19 vaccine emergency use authorization

An independent panel of experts has recommended the Food and Drug Administration (FDA) approve an official Emergency Use Authorization (EUA) for the Pfizer and BioNTech COVID-19 vaccine. This means th

Google to add COVID-19 vaccine information panels to Search

Google announced today it’s introducing a new search feature that will surface a list of authorized vaccines in users’ locations, as well as informational panels about each individual vacc

The UK approves the BioNTech/Pfizer COVID-19 vaccine for emergency use

The UK government has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, following the recommendation of the national medicines regulator. The UK is the first country to approve

Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today

Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from

AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy

AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the mo

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store

Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate

Week in Review: Venture-backed loneliness

Hello everyone and welcome back to Week in Review! Natasha here, subbing in for Lucas while he’s out. This week, we’ll talk about loneliness raising money and how Zoom fatigue is fueling innovatio

Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today

Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative tre

Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis

Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 va

Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial

Following fast on the heels of Pfizer’s announcement of its COVID-19 vaccine efficacy, Moderna is also sharing positive results from its Phase 3 trial on Monday. The biotech company says that it

Daily Crunch: Apple unveils new Macs

Apple announces “One More Thing” before the holiday season, Uber lets you reserve rides 30 days in advance and Spotify makes another podcast acquisition. This is your Daily Crunch for Nove

Carbon Health raises $100 million with plans to expand pop-up clinics ahead of COVID-19 vaccination programs

Carbon Health has raised a $100 million Series C funding round, led by Dragoneer Investment Group and including participation from prior investors Brookfield Technology Partners, DCVC and Builders VC.

What happens to high-flying startups if the pandemic trade flips?

So much can change in a day. This morning, news that a trial COVID-19 vaccine candidate had an effective rate of more than 90% shook the financial world. The Pfizer vaccine is reportedly so effective,
Load More